Insider Transactions in Q4 2023 at Azenta, Inc. (AZTA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,175
-16.71%
|
$289,800
$56.6 P/Share
|
|
Dec 01
2023
|
David Dong Wang SVP & GM, SMS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138
-1.44%
|
$7,866
$57.96 P/Share
|
|
Nov 17
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,179
-6.47%
|
$279,666
$54.83 P/Share
|
|
Nov 16
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,779
-2.24%
|
$147,287
$53.81 P/Share
|
|
Nov 16
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,448
+4.79%
|
$1,212,192
$54.57 P/Share
|
|
Nov 16
2023
|
Stephen S Schwartz CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,865
-2.94%
|
$681,845
$53.81 P/Share
|
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,582
+12.89%
|
$247,428
$54.57 P/Share
|
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,946
-10.05%
|
$156,138
$53.81 P/Share
|
|
Nov 16
2023
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+25.01%
|
$173,178
$54.57 P/Share
|
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+20.43%
|
$173,178
$54.57 P/Share
|
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Sale (or disposition) back to the issuer
|
Direct |
458
-4.7%
|
$24,274
$53.81 P/Share
|
|
Nov 16
2023
|
Herman Cueto EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,890
+44.05%
|
$804,060
$54.57 P/Share
|
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,291
+2.78%
|
$123,714
$54.57 P/Share
|
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,161
-2.7%
|
$114,533
$53.81 P/Share
|
|
Nov 16
2023
|
Violetta Hughes VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,374
+25.3%
|
$74,196
$54.57 P/Share
|
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
5,498
+4.89%
|
$296,892
$54.57 P/Share
|
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,831
-1.77%
|
$97,043
$53.81 P/Share
|
|
Nov 16
2023
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+50.0%
|
$173,178
$54.57 P/Share
|
|
Nov 15
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,297
+4.84%
|
$340,038
$54.13 P/Share
|
|
Nov 15
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,426
+3.62%
|
$887,004
$54.13 P/Share
|
|
Nov 15
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,107
+12.28%
|
$221,778
$54.13 P/Share
|
|
Nov 15
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
877
+8.26%
|
$47,358
$54.13 P/Share
|
|
Nov 15
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+3.47%
|
$155,250
$54.13 P/Share
|
|
Nov 15
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,559
+3.33%
|
$192,186
$54.13 P/Share
|